Clinical Trial Update: Intestinal Wall Remodeling (Infliximab Therapy) in Crohn's Disease Patients Undergoing Serial Computed Tomography (CT) Enterography

View source ↗

Summary

This completed clinical trial evaluated intestinal wall remodeling during infliximab therapy in Crohn's disease patients undergoing serial CT enterography.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Mayo Clinic | Conditions: Crohn's Disease | Status: COMPLETED